1. Home
  2. IDYA vs KGS Comparison

IDYA vs KGS Comparison

Compare IDYA & KGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • KGS
  • Stock Information
  • Founded
  • IDYA 2015
  • KGS 2011
  • Country
  • IDYA United States
  • KGS United States
  • Employees
  • IDYA N/A
  • KGS N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • KGS
  • Sector
  • IDYA Health Care
  • KGS
  • Exchange
  • IDYA Nasdaq
  • KGS Nasdaq
  • Market Cap
  • IDYA 2.9B
  • KGS 2.9B
  • IPO Year
  • IDYA 2019
  • KGS 2023
  • Fundamental
  • Price
  • IDYA $34.21
  • KGS $33.53
  • Analyst Decision
  • IDYA Buy
  • KGS Strong Buy
  • Analyst Count
  • IDYA 14
  • KGS 7
  • Target Price
  • IDYA $49.58
  • KGS $43.67
  • AVG Volume (30 Days)
  • IDYA 992.0K
  • KGS 1.6M
  • Earning Date
  • IDYA 11-04-2025
  • KGS 11-04-2025
  • Dividend Yield
  • IDYA N/A
  • KGS 5.85%
  • EPS Growth
  • IDYA N/A
  • KGS 224.29
  • EPS
  • IDYA N/A
  • KGS 0.84
  • Revenue
  • IDYA $214,834,000.00
  • KGS $1,284,748,000.00
  • Revenue This Year
  • IDYA $90.17
  • KGS $14.81
  • Revenue Next Year
  • IDYA $217.29
  • KGS $5.94
  • P/E Ratio
  • IDYA N/A
  • KGS $39.76
  • Revenue Growth
  • IDYA 5377.66
  • KGS 19.43
  • 52 Week Low
  • IDYA $13.45
  • KGS $29.25
  • 52 Week High
  • IDYA $34.66
  • KGS $50.43
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 68.23
  • KGS 42.58
  • Support Level
  • IDYA $31.15
  • KGS $32.55
  • Resistance Level
  • IDYA $34.66
  • KGS $34.67
  • Average True Range (ATR)
  • IDYA 1.58
  • KGS 1.25
  • MACD
  • IDYA 0.11
  • KGS -0.12
  • Stochastic Oscillator
  • IDYA 89.86
  • KGS 21.84

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About KGS Kodiak Gas Services Inc.

Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Contract Services and Other Services. Contract Services consists of operating Company-owned and customer-owned compression, and gas treating and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings.

Share on Social Networks: